292 related articles for article (PubMed ID: 31391007)
21. Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing.
Al-Shinnag M; Cheong PL; Goodwin A; Trent R; Yu B
Pathology; 2024 Jun; 56(4):468-472. PubMed ID: 38627125
[TBL] [Abstract][Full Text] [Related]
22. Exome sequencing of affected duos and trios uncovers PRUNE2 as a novel prostate cancer predisposition gene.
Cardoso M; Maia S; Brandão A; Sahasrabudhe R; Lott P; Belter N; Carvajal-Carmona LG; Paulo P; Teixeira MR
Br J Cancer; 2023 Apr; 128(6):1077-1085. PubMed ID: 36564567
[TBL] [Abstract][Full Text] [Related]
23. Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.
Raymond VM; Gray SW; Roychowdhury S; Joffe S; Chinnaiyan AM; Parsons DW; Plon SE;
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26590952
[TBL] [Abstract][Full Text] [Related]
24. Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations.
Sprissler R; Perkins B; Johnstone L; Babiker HM; Chalasani P; Lau B; Hammer M; Mahadevan D
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32570879
[TBL] [Abstract][Full Text] [Related]
25. Improving somatic exome sequencing performance by biological replicates.
Cebeci YE; Erturk RA; Ergun MA; Baysan M
BMC Bioinformatics; 2024 Mar; 25(1):124. PubMed ID: 38519906
[TBL] [Abstract][Full Text] [Related]
26. Whole genome sequencing analysis for cancer genomics and precision medicine.
Nakagawa H; Fujita M
Cancer Sci; 2018 Mar; 109(3):513-522. PubMed ID: 29345757
[TBL] [Abstract][Full Text] [Related]
27. Germline mutations in pediatric cancer cohort with mixed-ancestry Mexicans.
Alonso-Luna O; Mercado-Celis GE; Melendez-Zajgla J; Barquera R; Zapata-Tarres M; Juárez-Villegas LE; Mendoza-Caamal EC; Rey-Helo E; Borges-Yañez SA
Mol Genet Genomic Med; 2024 Jan; 12(1):e2332. PubMed ID: 38093606
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges.
Barbitoff YA; Ushakov MO; Lazareva TE; Nasykhova YA; Glotov AS; Predeus AV
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38271481
[TBL] [Abstract][Full Text] [Related]
29. Germline Cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations.
Liu Y; Gusev A; Kraft P
Cancer Res; 2023 Apr; 83(8):1191-1202. PubMed ID: 36745477
[TBL] [Abstract][Full Text] [Related]
30. Genetic predisposition to differentiated thyroid cancer in the Polish population.
Borowczyk M; Sypniewski M; Szyda J; Braszka M; Ziemnicka K; Ruchała M; Oszywa M; Król ZJ; Dobosz P
Pol Arch Intern Med; 2024 Mar; 134(3):. PubMed ID: 38165228
[TBL] [Abstract][Full Text] [Related]
31. Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial.
McGill BC; Wakefield CE; Tucker KM; Daly RA; Donoghoe MW; Vetsch J; Warby M; Fuentes-Bolanos NA; Barlow-Stewart K; Kirk J; Courtney E; O'Brien TA; Marshall GM; Pinese M; Cowley MJ; Tyrrell V; Deyell RJ; Ziegler DS; Hetherington K
Cancer; 2023 Nov; 129(22):3620-3632. PubMed ID: 37382186
[TBL] [Abstract][Full Text] [Related]
32. NetNorM: Capturing cancer-relevant information in somatic exome mutation data with gene networks for cancer stratification and prognosis.
Le Morvan M; Zinovyev A; Vert JP
PLoS Comput Biol; 2017 Jun; 13(6):e1005573. PubMed ID: 28650955
[TBL] [Abstract][Full Text] [Related]
33. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.
Ma X; Liu Y; Liu Y; Alexandrov LB; Edmonson MN; Gawad C; Zhou X; Li Y; Rusch MC; Easton J; Huether R; Gonzalez-Pena V; Wilkinson MR; Hermida LC; Davis S; Sioson E; Pounds S; Cao X; Ries RE; Wang Z; Chen X; Dong L; Diskin SJ; Smith MA; Guidry Auvil JM; Meltzer PS; Lau CC; Perlman EJ; Maris JM; Meshinchi S; Hunger SP; Gerhard DS; Zhang J
Nature; 2018 Mar; 555(7696):371-376. PubMed ID: 29489755
[TBL] [Abstract][Full Text] [Related]
34. Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facility.
Kawamura M; Shirota H; Niihori T; Komine K; Takahashi M; Takahashi S; Miyauchi E; Niizuma H; Kikuchi A; Tada H; Shimada M; Kawamorita N; Kanamori M; Sugiyama I; Tsubata M; Ichikawa H; Yasuda J; Furukawa T; Aoki Y; Ishioka C
J Hum Genet; 2023 Jun; 68(6):399-408. PubMed ID: 36804482
[TBL] [Abstract][Full Text] [Related]
35. Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.
Offit K; Tkachuk KA; Stadler ZK; Walsh MF; Diaz-Zabala H; Levin JD; Steinsnyder Z; Ravichandran V; Sharaf RN; Frey MK; Lipkin SM; Robson ME; Hamilton JG; Vijai J; Mukherjee S
J Clin Oncol; 2020 May; 38(13):1398-1408. PubMed ID: 31922925
[TBL] [Abstract][Full Text] [Related]
36. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
Liu J; Lichtenberg T; Hoadley KA; Poisson LM; Lazar AJ; Cherniack AD; Kovatich AJ; Benz CC; Levine DA; Lee AV; Omberg L; Wolf DM; Shriver CD; Thorsson V; ; Hu H
Cell; 2018 Apr; 173(2):400-416.e11. PubMed ID: 29625055
[TBL] [Abstract][Full Text] [Related]
37. Germline Variants in Cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors.
Jovanović A; Tošić N; Marjanović I; Komazec J; Zukić B; Nikitović M; Ilić R; Grujičić D; Janić D; Pavlović S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139220
[TBL] [Abstract][Full Text] [Related]
38. Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Ding L; Bailey MH; Porta-Pardo E; Thorsson V; Colaprico A; Bertrand D; Gibbs DL; Weerasinghe A; Huang KL; Tokheim C; Cortés-Ciriano I; Jayasinghe R; Chen F; Yu L; Sun S; Olsen C; Kim J; Taylor AM; Cherniack AD; Akbani R; Suphavilai C; Nagarajan N; Stuart JM; Mills GB; Wyczalkowski MA; Vincent BG; Hutter CM; Zenklusen JC; Hoadley KA; Wendl MC; Shmulevich L; Lazar AJ; Wheeler DA; Getz G;
Cell; 2018 Apr; 173(2):305-320.e10. PubMed ID: 29625049
[TBL] [Abstract][Full Text] [Related]
39. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma.
Patiño-García A; Guruceaga E; Andueza MP; Ocón M; Fodop Sokoudjou JJ; de Villalonga Zornoza N; Alkorta-Aranburu G; Uria IT; Gurpide A; Camps C; Jantus-Lewintre E; Navamuel-Andueza M; Sanmamed MF; Melero I; Elgendy M; Fusco JP; Zulueta JJ; de-Torres JP; Bastarrika G; Seijo L; Pio R; Montuenga LM; Hernáez M; Ochoa I; Perez-Gracia JL
EBioMedicine; 2024 Apr; 102():105048. PubMed ID: 38484556
[TBL] [Abstract][Full Text] [Related]
40. Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry.
Slavin TP; Van Tongeren LR; Behrendt CE; Solomon I; Rybak C; Nehoray B; Kuzmich L; Niell-Swiller M; Blazer KR; Tao S; Yang K; Culver JO; Sand S; Castillo D; Herzog J; Gray SW; Weitzel JN
J Natl Cancer Inst; 2018 Oct; 110(10):1059-1066. PubMed ID: 29618041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
